Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irbesartan for Hepatic Fibrosis in Chronic Hepatitis C
NCT00265642Phase 3Completed
- Sponsor
- ANRS
- Start
- Oct 2006
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of irbesartan in hepatitis C virus infection, sponsored by ANRS. Started Oct 2006; status: completed.
02
Drugs
irbesartan
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT00265642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00265642.